Stay Updated with the Latest Evotec SE EVT.DE News in Real Time
Find EVT.DE news now at Meyka AI. Stay informed with the latest Evotec SE stocks updates, including price news, market analysis, and expert insights.
Evotec SE (EVT.SW) Climbs 0.5% as Drug Developer Navigates Healthcare Headwinds
EVT.SW stock rises 0.5% to CHF5.035 on SIX. Evotec SE faces profitability challenges but maintains market position in drug discovery.
Bayer AG (BAYN.SW) Surges 5.5% on Strong Earnings Recovery
Bayer AG stock jumps 5.5% to CHF35.84 on SIX after earnings beat. BAYN.SW analysis shows recovery in pharmaceuticals and crop science segments.
EVT.SW Stock Surges 11.68% on April 17, 2026 – Evotec SE Gains
EVT.SW stock jumps 11.68% to CHF 5.115 on SIX. Evotec SE shows strong intraday gains despite D+ rating. Real-time analysis inside.
Evotec SE (EVT.DE XETRA) 06 Apr 2026 earnings preview: valuation test ahead
EVT.DE stock trades at EUR 4.50 ahead of 08 Apr 2026 earnings; we review guidance risks, Meyka forecast and price targets for traders
EVT.DE Evotec SE (XETRA) pre-market 03 Apr 2026: Q4 results due 08 Apr, catalyst ahead
EVT.DE stock pre-market snapshot and earnings spotlight ahead of 08 Apr 2026 results
GXI.DE Gerresheimer AG XETRA pre-market €19.34 18 Mar 2026: earnings set to guide
GXI.DE stock pre-market at €19.34 ahead of 19 Mar 2026 earnings; we examine margins, leverage, and a €24.00 base price target
0252.HK Southeast Asia P&F HKSE HK$1.60 pre-market 13 Mar 2026: Oversold setup
Pre-market look at 0252.HK stock at HK$1.60 on 13 Mar 2026. Oversold bounce setup, valuation and Meyka AI forecast
BIO.DE Biotest AG on XETRA pre-market: €42.20 shows oversold bounce opportunity
BIO.DE stock pre-market snapshot at €42.20; oversold bounce setup with short-term upside potential and model forecast
BIO.DE Biotest AG XETRA 15 Jan 2026: Oversold bounce from €42.20, watch €43.50
Intraday oversold bounce analysis for BIO.DE stock at €42.20 on XETRA with Meyka AI forecast and trade levels